AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Tandem Diabetes Care Inc. (TNDM)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

32.04

0.32 (1.01%)

At close: Feb 20, 2025, 3:59 PM

32.33

0.91%

After-hours: Feb 20, 2025, 04:02 PM EST

undefined% (undefined)

Bid	31
Market Cap	2.10B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.94
PE Ratio (ttm)	-16.52
Forward PE	n/a
Analyst	Buy

Ask	32.5
Volume	842,279
Avg. Volume (20D)	1,067,372
Open	31.57
Previous Close	31.72
Day's Range	31.25 - 32.21
52-Week Range	24.42 - 53.69
Beta	undefined

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technolo...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Nov 14, 2013

Employees 2,400

Stock Exchange NASDAQ

Ticker Symbol TNDM

Website https://www.tandemdiabetes.com

Full Company Profile

Analyst Forecast

According to 15 analyst ratings, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is $55, which is an increase of 71.66% from the latest price.

Buy 86.67%

Hold 13.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Tandem Diabetes Care Inc. is scheduled to release its earnings on Feb 26, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+7.94%

Tandem Diabetes Care shares are trading higher ami... Unlock content with Pro Subscription

2 months ago

+6.14%

Tandem Diabetes Care shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.

News

1 month ago · zacks.com

Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?

TNDM's shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario is concerning.

1 month ago · zacks.com

Reasons to Retain TNDM Stock in Your Portfolio for Now

A robust diabetes market and several strategic developments raise investors' optimism for Tandem Diabetes.

1 month ago · businesswire.com

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2024 results after ...

1 month ago · zacks.com

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

TNDM enters a multi-year research collaboration with the UVA Center for Diabetes Technology for the development of AID systems.

1 month ago · businesswire.com

Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collabor...

2 months ago · zacks.com

TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada

Tandem Diabetes' t:slim X2 insulin pump is now compatible with Dexcom G7 CGM in Canada.

3 months ago · businesswire.com

Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the ...